Loading
CS
CardioComm Solutions, Inc. Stock: price and insider trades · Canada
Insider Decl.
124
Thresholds
n/a
Buy Volume
€3,220
7 ops. · all time
Sell Volume
€397,485
73 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$0.01
Analyst consensus
Income statement
RevenueCA$272.2k
Gross profitCA$221.7k81% margin
EBITDA-CA$453.4k-167% margin
Net income-CA$529.5k-236.0% margin
Valuation
Beta-1.94
Balance sheet & cash
Market capCA$2M
Total debtCA$691.2k
Free Cash Flow-CA$455.6k
Profitability & ownership
ROA-154.8%
% insiders47.4%
% institutions0.0%
Last declaration on 12 November 2025
Declarations124 total
Common SharesTSXSEDI:4604813
65,600 shares@ CA$0.01519.0% of flowCommon SharesTSXSEDI:4604815
280,000 shares@ CA$0.01581.0% of flowCommon SharesTSXSEDI:4604811
Common SharesTSXSEDI:4604820
65,600 shares@ CA$0.0150.7% of flowCommon SharesTSXSEDI:4604821
1,230,000 shares@ CA$0.0148.6% of flowCommon SharesTSXSEDI:4553297
1,192,500 shares@ CA$0.012.1% of flowCommon SharesTSXSEDI:4553290
1,080,000 shares@ CA$0.0168.1% of flowCommon SharesTSXSEDI:4553295
27,442,571 shares@ CA$0.0188.5% of flowCommon SharesTSXSEDI:4346594
2,352,466 shares@ CA$0.014.0% of flowCommon SharesTSXSEDI:4346593
2,083,575 shares@ CA$0.016.7% of flowCommon SharesTSXSEDI:4346596
89,500 shares@ CA$0.0512.0% of flowCommon SharesTSXSEDI:4069301
44,000 shares@ CA$0.0522.2% of flowCommon SharesTSXSEDI:4069312
1,298,182 shares@ CA$0.05515.3% of flowCommon SharesTSXSEDI:3742800
65,000 shares@ CA$0.0660.3% of flowCommon SharesTSXSEDI:3742805
65,000 shares@ CA$0.0617.6% of flowCommon SharesTSXSEDI:3742819
121,250 shares@ CA$0.0631.0% of flowCommon SharesTSXSEDI:3742813
500,000 shares@ CA$0.054.9% of flowCommon SharesTSXSEDI:3666905
194,000 shares@ CA$0.0526.0% of flowCommon SharesTSXSEDI:3497583
104,000 shares@ CA$0.0519.2% of flowCommon SharesTSXSEDI:3497586
104,000 shares@ CA$0.0544.9% of flowCommon SharesTSXSEDI:3497568
104,000 shares@ CA$0.0552.3% of flowCommon SharesTSXSEDI:3497578
144,000 shares@ CA$0.0552.2% of flowCommon SharesTSXSEDI:3497588
43,333 shares@ CA$0.0611.6% of flowCommon SharesTSXSEDI:3390604
60,000 shares@ CA$0.0653.3% of flowCommon SharesTSXSEDI:3390608
25 of 124 declarations
About CardioComm Solutions, Inc.
One 10% security holder, Anatoly Langer, accounts for most of the record of CardioComm Solutions, Inc.: 72 of the 121 filings, all sales, including EUR 33,341 on May 29, 2017 and EUR 32,127 on May 24, 2017. The largest sale in the record, EUR 51,162 on July 28, 2017, is by Etienne Anthony Grima, a director, who has 23 filings, 4 of them purchases and 1 a sale.
In all, 73 sales come to EUR 397,485 (median EUR 3,054) against 7 purchases for just EUR 3,220 (median EUR 325), so purchases are only 9% of open-market trades. The largest purchases are by Steven Vincent Benyo, a director: EUR 1,192 on March 29, 2018 and EUR 665 on August 9, 2018, then EUR 634 on February 26, 2019 for Etienne Anthony Grima.
Read moreShow less
Eight insiders filed between 2016 and 2025, with a peak of 66 filings in 2016. The record holds 17 grants and 8 option exercises. The Toronto-listed Health Care company has a market capitalisation of CAD 1,975,821, and insiders hold 47.4%. Over the last twelve months there are 5 filings.
